JPMorgan Chase & Co’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3
| Closed | – | – | 6907 |
|
|
2023
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 6704 |
|
|
2023
Q2 | $2 | Hold |
3
| – | – | ﹤0.01% | 5948 |
|
|
2023
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 6253 |
|
|
2022
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 6102 |
|
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 5961 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 6042 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 6062 |
|
|
2021
Q4 | $0 | Sell |
3
-4,250
| -100% | – | ﹤0.01% | 6015 |
|
|
2021
Q3 | $13K | Sell |
4,253
-33,353
| -89% | -$102K | ﹤0.01% | 5203 |
|
|
2021
Q2 | $113K | Buy |
37,606
+30,341
| +418% | +$91.2K | ﹤0.01% | 4728 |
|
|
2021
Q1 | $24K | Buy |
7,265
+1,643
| +29% | +$5.43K | ﹤0.01% | 4925 |
|
|
2020
Q4 | $23K | Buy |
5,622
+770
| +16% | +$3.15K | ﹤0.01% | 4563 |
|
|
2020
Q3 | $26K | Buy |
4,852
+822
| +20% | +$4.41K | ﹤0.01% | 4446 |
|
|
2020
Q2 | $27K | Buy |
4,030
+1,496
| +59% | +$10K | ﹤0.01% | 4364 |
|
|
2020
Q1 | $8K | Sell |
2,534
-89
| -3% | -$281 | ﹤0.01% | 4484 |
|
|
2019
Q4 | $18K | Buy |
2,623
+4
| +0.2% | +$27 | ﹤0.01% | 4439 |
|
|
2019
Q3 | $10K | Buy |
2,619
+425
| +19% | +$1.62K | ﹤0.01% | 4574 |
|
|
2019
Q2 | $8K | Sell |
2,194
-185
| -8% | -$675 | ﹤0.01% | 4670 |
|
|
2019
Q1 | $9K | Sell |
2,379
-557
| -19% | -$2.11K | ﹤0.01% | 4651 |
|
|
2018
Q4 | $22K | Buy |
+2,936
| New | +$22K | ﹤0.01% | 4484 |
|